CompletedNot Applicable

The Effect of Nefopam on Catheter-related Bladder Discomfort

South Korea110 participantsStarted 2017-03-31

Plain-language summary

In the present study, the investigators evaluated whether nefopam 20 mg reduce the catheter-related bladder discomfort in patients undergoing foley catheter insertion

Who can participate

Age range20 Years – 75 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients scheduled to insert the catheter a new foley catheter more than 14 Fr in the operation site,
✓. Adults 20 to 75years of age
✓. American Society of Anesthesiologists Physical Classification 1,2 patients
✓. Patients who pre-agreed to the study
✓. Male patient

Exclusion criteria

✕. Neurogenic bladder
✕. Patients diagnosed with irritable bladder
✕. study drug sensitive or contraindicated
✕. Patients with central nervous system or neurological disorder (epilepsy, patients receiving MAO inhibitor)
✕. Patients with urethral and prostate disorders
✕. Patients with previous history of myocardial infarction
✕. Patients with closed angle glaucoma

What they're measuring

catheter-related bladder discomfort

Timeframe: postoperative 1 hour

Trial details

NCT IDNCT03130010

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12-31

View on ClinicalTrials.gov More Nefopam trials